Table 1 Baseline characteristics and balance assessment of subjects after PSM
From: Investigation of multiple nosocomial infections using a semi-Markov multi-state model
Variable | Case group(n = 1751) | Control group (n = 1751) | P-value |
|---|---|---|---|
Characteristic | |||
 Age (mean (SD)) | 47.51(23.41) | 47.52(21.78) | 0.983 |
 AI (%) | 398(22.70) | 379(21.60) | 0.464 |
 Gender (%) | 701(40.0) | 694(39.60) | 0.836 |
 RW (mean (SD)) | 2.82(3.14) | 2.75(3.03) | 0.548 |
 Admission (%) |  |  | 0.353 |
  Emergency | 809(46.20) | 799(45.60) |  |
  Others | 75(4.30) | 60(3.40) |  |
  Outpatient | 867(49.50) | 892(50.90) |  |
 Charlson index (mean (SD)) | 3.17(2.99) | 3.07(2.87) | 0.347 |
 Surgery (%) | 870(49.70) | 947(54.10) | 0.01 |
 IMV (%) | 241(13.80) | 223(12.70) | 0.397 |
 CVC (%) | 508(29.00) | 492(28.10) | 0.575 |
 IC (%) | 928(53.00) | 963(55.00) | 0.249 |
 Use.Antibiotics (%) | 1661(94.90) | 1129(64.50) |  < 0.001 |
 Coantibiotics (%) | 1172(66.90) | 411(23.50) |  < 0.001 |
Pathogenes |  |  |  < 0.001 |
 Escherichia coli (%) | 207(19.08%) | 19(6.86%) |  |
 Klebsiella pneumoniae (%) | 136(12.53%) | 51(18.41%) |  |
 Pseudomonas aeruginosa (%) | 105(9.68%) | 25(9.03%) |  |
 Staphylococcus aureus (%) | 98(9.03%) | 15(5.42%) |  |
 Candida albicans (%) | 67(6.18%) | 27(9.75%) |  |
 Acinetobacter baumannii (%) | 66(6.08%) | 11(3.97%) |  |
 Enterobacter cloacae (%) | 48(4.42%) | 3(1.08%) |  |
 Enterococcus faecalis (%) | 37(3.41%) | 3(1.08%) |  |
 Stenotrophomonas maltophilia (%) | 28(2.58%) | 11(3.97%) |  |
 Staphylococcus epidermidis (%) | 25(2.30%) | 5(1.81%) |  |
 Enteroaerogen (%) | 19(1.75%) | 4(1.44%) |  |
 Serratia marcescens (%) | 13(1.20%) | 1(0.36%) |  |
 Staphylococcus hominis (%) | 13(1.20%) | 3(1.08%) |  |
 Streptococcus pneumoniae (%) | 13(1.20%) | 6(2.17%) |  |
 Proteus mirabilis (%) | 12(1.11%) | 3(1.08%) |  |
 Candida glabrata (%) | 12(1.11%) | 3(1.08%) |  |
 Ureaplasma Urealyticum (%) | 11(1.01%) | 3(1.08%) |  |
 Monilia tropicalis (%) | 10(0.92%) | 6(2.17%) |  |
 Others (%) | 165(15.21%) | 78(28.16%) |  |
Infection sites | |||
 LRT(%) | 589(30.36%) | \ |  |
 UT(%) | 229(11.80%) | \ |  |
 URT(%) | 225(11.60%) | \ |  |
 SST(%) | 187(9.64%) | \ |  |
 SS(%) | 182(9.38%) | \ |  |
 BS(%) | 174(8.97%) | \ |  |
 ADS(%) | 119(6.13%) | \ |  |
 Others(%) | 116(5.98%) | \ |  |
 GT(%) | 55(2.84%) | \ |  |
 CNS(%) | 31(1.60%) | \ |  |
 OC(%) | 19(0.98%) | \ |  |
 PC(%) | 11(0.57%) | \ |  |
 Bone & Joint(%) | 3(0.15%) | \ |  |